Ask AI: Evaluate one cell-based therapeutic solution to engineer cartilage using research from the last two years.

One cell-based therapeutic solution to engineer cartilage that has been studied in the last two years is the use of human umbilical cord mesenchymal stromal cells (hUCMSCs). These cells have been used in combination with a type I collagen hydrogel scaffold to form engineered cartilage tissue in vitro. This technique has proven to be capable of producing cartilage-like tissue with high cell viability and mechanical properties, while also providing enhanced regenerative and cartilage regeneration potential. Furthermore, the hUCMSCs in this system have also been found to possess good osteogenic potential, making them a good potential tool for cartilage regeneration. This research demonstrates the potential of this cell-based solution to effectively engineer cartilage tissue in vitro.